Arizona Tribune - Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

NYSE - LSE

RBGPF	0.12%	82.5	$
CMSC	0.28%	22.895	$
BCC	-3.01%	69.74	$
VOD	-0.31%	14.325	$
NGG	-1.91%	85.76	$
GSK	-0.01%	52.055	$
RYCEF	-4.73%	15.85	$
RELX	0.38%	33.99	$
RIO	-4.18%	84.2	$
BCE	0.43%	25.86	$
JRI	-0.84%	12.22	$
CMSD	0.17%	22.93	$
BTI	-0.19%	57.98	$
AZN	-0.21%	188.03	$
BP	4.24%	46.585	$

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

BOULEVARD 19.03.2026

SAN DIEGO, CA / ACCESS Newswire / March 19, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, announced today that James Rolke, Revelation's Chief Executive Officer, and Chester S. Zygmont, III, Revelation's Chief Financial Officer, will be attending the 38^th Annual Roth Conference, in Dana Point, CA, on Monday and Tuesday March 23^rd and 24^th. On Tuesday, March 24, 2026, at 2:00 p.m. PT, the Company will participate in a fireside chat.

Text size:

The fireside chat will be webcast live here and available on our Investors section of the Revelation Biosciences website, www.RevBiosciences.com, after the meeting.

Investors who wish to schedule a meeting with Revelation's management during the conference should contact their Roth representative.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on rebalancing inflammation using its proprietary formulation, Gemini. Revelation has multiple ongoing programs to evaluate Gemini as a treatment for acute kidney injury, a treatment of chronic kidney disease, prevention of post-surgical infection, and a treatment to reduce hyperinflammation and infection associated with severe burn.

For more information, please visit www.RevBiosciences.com.

Company Contacts

Mike Porter
Investor Relations
Porter LeVay & Rose Inc.
Email: [email protected]

Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: [email protected]

SOURCE: Revelation Biosciences, Inc.

View the original press release on ACCESS Newswire

R.Lee--AT

Featured

Wimbledon expansion plan gets legal boost

Social media addiction trial jury deliberations continue

Black Book Research Releases 2026 Market Report on Spanish-Speaking Latin America, Finding 18 Distinct Digital Healthcare Buyer Environments Reshaping EHR, Interoperability, Analytics, and RCM Investment

Remergify Announces Strategic Partnership with Farrington Capital Group and Near Infrared Imaging, Inc to Incorporate AI into Near-Infrared Medical Technology